Danish pharmaceutical giant Novo Nordisk A/S (NYSE:NVO) submitted a Citizen Petition to the FDA requesting the exclusion of ...
The FDA has approved Liraglutide Injection, the first generic version of Victoza, for the treatment of type 2 diabetes.
The U.S. Food and Drug Administration has approved the first generic referencing Victoza (liraglutide; Hikma Pharmaceuticals) ...
In a citizen petition posted by the FDA this week, Novo urged the regulator to restrict the ability of compounding pharmacies ...
HealthDay on MSN12d
FDA Approves Generic GLP-1 Medicine For Diabetes TreatmentThe U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a ...
The generic liraglutide includes a Boxed Warning to advise ... and constipation. “The FDA supports development of complex generic drugs, such as GLP-1s, by funding research and informing ...
Novo Nordisk (NOVO) is petitioning the FDA to exclude its diabetes drug liraglutide, also known as Victoza, from a list of drugs that are allowed to be compounded. In a Citizen Petition posted on ...
Hosted on MSN8d
FDA Approves First Generic Liraglutide Injection, Ushering in a New Era for Type 2 Diabetes TreatmentThe fight against type 2 diabetes just reached a groundbreaking milestone. Last week, the U.S. Food and Drug Administration ...
According to the Company, the generic product will launch immediately. The Food and Drug Administration (FDA) has approved Liraglutide Injection, the first generic version of Victoza ®.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback